VBI Vaccines
VBIV
$0.58
Share price
2.30%
Change (1 day)
-79.84%
Change (1 year)
Categories
VBI Vaccines (VBIV) - P/B ratio
P/B ratio as of May 2024 : 2.20
According to VBI Vaccines
's latest financial reports the company has a price-to-book ratio of 2.20.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
VBI Vaccines - P/B ratio (from 2008 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.85 | 17.45% |
| 2022-12-31 | 1.57 | -62.38% |
| 2021-12-31 | 4.18 | 7.94% |
| 2020-12-31 | 3.88 | 39.08% |
| 2019-12-31 | 2.79 | 75.62% |
| 2018-12-31 | 1.59 | -30.22% |
| 2017-12-31 | 2.27 | 68.86% |
| 2016-12-31 | 1.35 | -82.63% |
| 2015-12-31 | 7.76 | 2281.39% |
| 2014-12-31 | 0.3257 | 16.56% |
| 2013-12-31 | 0.2794 | -40.65% |
| 2012-12-31 | 0.4708 | -59.91% |
| 2011-12-31 | 1.17 | -88.66% |
| 2010-12-31 | 10.4 | 94.6% |
| 2009-12-31 | 5.32 | 234.76% |
| 2008-12-31 | 1.59 | |
| 2007-12-31 | N/A | |
| 2006-12-31 | N/A | |
| 2005-12-31 | N/A | |
| 2004-12-31 | N/A | |
| 2003-12-31 | N/A | |
| 2002-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | 1.96 | -10.99% | 🇺🇸 USA |
 Curis CRIS | 4.95 | 124.80% | 🇺🇸 USA |
 Myriad Genetics MYGN | 2.22 | 0.89% | 🇺🇸 USA |